Mark Gardner

Mark Gardner

Company: Quest Diagnostics

Job title: Senior Vice President, Molecular Genomics & Oncology


Panel Discussion: ctDNA Analysis has the Potential to Provide High-Definition Insights in Drug Development 6:15 pm

Stratify patients for trials   Identify therapy response and resistance Quantifiably track variants Assess treatment outcome earlyRead more

day: Quest Diagnostics Engager

Leveraging MRD to Provide High-Definition Insights for Clinical Trials 9:10 am

Through the recent acquisition of Haystack Oncology, Quest Diagnostics aims to combine its expertise in oncology, genomics, and pathology with Haystack's next generation liquid biopsy technology. This collaboration will drive the development of reliable MRD tests and expand their accessibility for a range of cancer types, including colorectal, breast, and lung cancers. ctDNA analysis has…Read more

day: Day 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.